Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 6.1 earthquake jolts eastern Taiwan
04/27/2024 02:54 AM - Politics
A discussion with Cosette Wu, the woman behind the Harvard speech disruption
04/26/2024 11:25 PM - Society
32 indicted in NT$800 million crypto fraud case
04/26/2024 10:50 PM - Business
Taiwan, U.S. to hold new round of trade talks in Taipei next week: Office
04/26/2024 10:18 PM - Culture
Budapest picked as 2024 Taipei Film Festival's 'City in Focus'
04/26/2024 10:00 PM